Condition
HSCT clinical trials and research
As of November 12, 2026, Find a Trial lists 5 HSCT clinical trials that are recruiting, at sites in 3 countries (most in France (3), United States (1), China (1)). By phase: Phase 3 (1), Phase 1/2 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest HSCT clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| See how well the lungs distribute dissolved xenon gas during MRI in HSCT patients and others | Phase 1/2 | Cincinnati, Ohio | Recruiting | Sep 16, 2026 |
| Tezepelumab for chronic bronchial disease due to BOS after allogeneic stem cell transplant | Phase 2 | Besançon and 5 other locations | Recruiting | Aug 18, 2026 |
| Romiplostim to speed platelet recovery after haploidentical stem cell transplant | Phase 1 | Hangzhou | Recruiting | Jan 7, 2026 |
| Lowering the total dose of cyclophosphamide after haploidentical stem cell transplant for blood cancers | Phase 3 | Paris | Recruiting | Sep 25, 2025 |
| Cardiovascular problems after allogeneic stem cell transplant | — | Paris | Recruiting | Sep 5, 2025 |
All recruiting trials (5)
-
See how well the lungs distribute dissolved xenon gas during MRI in HSCT patients and others
This study tests a special MRI method using hyperpolarized xenon gas to visualize how gas and dissolved xenon move through the lungs in people who have HSCT, respiratory issues, or are healthy controls.
-
Tezepelumab for chronic bronchial disease due to BOS after allogeneic stem cell transplant
This study tests whether tezepelumab can help adults with bronchial obstruction caused by bronchiolitis obliterans syndrome after an allogeneic stem cell transplant.
-
Romiplostim to speed platelet recovery after haploidentical stem cell transplant
This trial will test whether weekly romiplostim helps adults with AML, MDS, or other blood cancers recover platelets faster after a haploidentical stem cell transplant.
-
Lowering the total dose of cyclophosphamide after haploidentical stem cell transplant for blood cancers
This trial tests whether a reduced total dose of cyclophosphamide after a haploidentical stem cell transplant can improve outcomes for adults with blood cancers.
-
Cardiovascular problems after allogeneic stem cell transplant
This study looks at heart-related problems after allogeneic hematopoietic stem cell transplantation to see how often they occur and what factors might predict them.
Related topics
Quick answers
How many HSCT clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in France (3 trials), United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1/2: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.